Search Results - "Wienkers, LC"

Refine Results
  1. 1

    Factors confounding the successful extrapolation of in vitro CYP3A inhibition information to the in vivo condition by Wienkers, Larry C.

    “…For the most part, the majority of adverse drug–drug interactions, which are pharmacokinetic in origin, can be understood in terms of alterations of cytochrome…”
    Get full text
    Journal Article
  2. 2

    Predicting in vivo drug interactions from in vitro drug discovery data by Wienkers, Larry C, Heath, Timothy G

    Published in Nature reviews. Drug discovery (01-10-2005)
    “…In vitro screening for drugs that inhibit cytochrome P450 enzymes is well established as a means for predicting potential metabolism-mediated drug interactions…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Pyrene·Pyrene Complexes at the Active Site of Cytochrome P450 3A4:  Evidence for a Multiple Substrate Binding Site by Dabrowski, Michael J, Schrag, Michael L, Wienkers, Larry C, Atkins, William M

    Published in Journal of the American Chemical Society (09-10-2002)
    “…Cytochrome P450 monooxygenases (CYPs) metabolize nearly all drugs and toxins. Recently, it has become clear that CYPs exhibit both homotropic and heterotropic…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7

    Covalent Alteration of the CYP3A4 Active Site: Evidence for Multiple Substrate Binding Domains by Schrag, Michael L., Wienkers, Larry C.

    Published in Archives of biochemistry and biophysics (01-07-2001)
    “…The inhibition of CYP3A4-mediated oxidation of triazolam and testosterone was assessed in the presence of a selection of known CYP3A4 substrates and…”
    Get full text
    Journal Article
  8. 8

    IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES by WYNALDA, Michael A, HUTZLER, J. Matthew, KOETS, Michael D, PODOLL, Terry, WIENKERS, Larry C

    Published in Drug metabolism and disposition (01-07-2003)
    “…Incubations with human liver and gut microsomes revealed that the antibiotic, clindamycin, is primarily oxidized to form clindamycin sulfoxide. In this report,…”
    Get full text
    Journal Article
  9. 9

    Topological Alteration of the CYP3A4 Active Site by the Divalent Cation Mg2 by SCHRAG, Michael L, WIENKERS, Larry C

    Published in Drug metabolism and disposition (01-10-2000)
    “…Phenyldiazene reacted with lymphoblast-expressed CYP3A4 to give a stable phenyl-iron complex that could be induced to rearrange in situ producing approximately…”
    Get full text
    Journal Article
  10. 10

    Inhibition of Cytochrome P450 2D6:  Structure−Activity Studies Using a Series of Quinidine and Quinine Analogues by Hutzler, J. Matthew, Walker, Gregory S, Wienkers, Larry C

    Published in Chemical research in toxicology (01-04-2003)
    “…Several pharmacophore models have suggested that substrates and inhibitors of cytochrome P450 2D6 (P450 2D6) possess a nitrogen with a positive charge that…”
    Get full text
    Journal Article
  11. 11

    Bioactivation of the anticancer agent CPT-11 to SN-38 by human hepatic microsomal carboxylesterases and the in vitro assessment of potential drug interactions by SLATTER, J. G, SU, P, SAMS, J. P, SCHAAF, L. J, WIENKERS, L. C

    Published in Drug metabolism and disposition (01-10-1997)
    “…Human hepatic microsomes were used to investigate the carboxylesterase-mediated bioactivation of CPT-11 to the active metabolite, SN-38. SN-38 formation…”
    Get full text
    Journal Article
  12. 12

    Oxidation of the Novel Oxazolidinone Antibiotic Linezolid in Human Liver Microsomes by WYNALDA, M. A, HAUER, M. J, WIENKERS, L. C

    Published in Drug metabolism and disposition (01-09-2000)
    “…In vitro studies were conducted to identify the hepatic enzyme(s) responsible for the oxidative metabolism of linezolid. In human liver microsomes, linezolid…”
    Get full text
    Journal Article
  13. 13

    Triazolam Substrate Inhibition: Evidence of Competition for Heme-Bound Reactive Oxygen Within the CYP3A4 Active Site by SCHRAG, Michael L, WIENKERS, Larry C

    Published in Drug metabolism and disposition (01-01-2001)
    “…In human liver microsomes, triazolam is principally metabolized by CYP3A4 to form two metabolites, 1′-hydroxytriazolam (1′OHTz) and 4-hydroxytriazolam…”
    Get full text
    Journal Article
  14. 14

    Effect of carbonate anion on cytochrome P450 2D6-mediated metabolism in vitro: the potential role of multiple oxygenating species by Hutzler, J.Matthew, Powers, Frank J, Wynalda, Michael A, Wienkers, Larry C

    Published in Archives of biochemistry and biophysics (15-09-2003)
    “…Studies were designed to investigate various anions and their effects on cytochrome P450 2D6-mediated metabolism in vitro. Incubations were initially performed…”
    Get full text
    Journal Article
  15. 15

    Cytochrome P-450-Mediated Metabolism of the Individual Enantiomers of the Antidepressant Agent Reboxetine in Human Liver Microsomes by WIENKERS, L. C, ALLIEVI, C, HAUER, M. J, WYNALDA, M. A

    Published in Drug metabolism and disposition (01-11-1999)
    “…In vitro studies were conducted to identify the hepatic cytochrome P-450 (CYP) enzymes responsible for the oxidative metabolism of the individual enantiomers…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Assessment of Potential Interactions Between Dopamine Receptor Agonists and Various Human Cytochrome P450 Enzymes Using a Simple In Vitro Inhibition Screen by WYNALDA, M. A, WIENKERS, L. C

    Published in Drug metabolism and disposition (01-10-1997)
    “…The selectivity of inhibition for four dopamine receptor agonists (pramipexole, ropinirole, pergolide, and bromocriptine) on six human cytochrome P450 enzyme…”
    Get full text
    Journal Article
  18. 18

    Multiple Cytochrome P450 Enzymes Responsible for the Oxidative Metabolism of the Substituted (S)-3-Phenylpiperidine, (S,S)-3-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine Hydrochloride, in Human Liver Microsomes by WIENKERS, Larry C, WYNALDA, Michael A

    Published in Drug metabolism and disposition (01-12-2002)
    “…( S , S )-3-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine hydrochloride [(−)-OSU6162] is a weak dopamine D2 receptor modulator that possesses potential for…”
    Get full text
    Journal Article
  19. 19

    Formation of (R)-8-hydroxywarfarin in human liver microsomes. A new metabolic marker for the (S)-mephenytoin hydroxylase, P4502C19 by Wienkers, L C, Wurden, C J, Storch, E, Kunze, K L, Rettie, A E, Trager, W F

    Published in Drug metabolism and disposition (01-05-1996)
    “…Kinetic studies demonstrate that two forms of human liver cytochrome P450 are responsible for the formation of (R)-8-hydroxywarfarin: a low-affinity enzyme (KM…”
    Get more information
    Journal Article
  20. 20

    Problems associated with in vitro assessment of drug inhibition of CYP3A4 and other P-450 enzymes and its impact on drug discovery by Wienkers, Larry C

    “…The cytochromes P-450 recognize and metabolize a broad range of structurally diverse therapeutic agents. As a consequence, many clinically relevant drug–drug…”
    Get full text
    Journal Article